Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients

Journal of Surgical Research

Volumn 94, Issue 1, 2000, Pages 56-60

  So, Jimmy B Y ^a   Samarasinge, Kamani ^a   Raju, Gangaraju C ^a   Moochhala, Shabbir M ^a   Ti, Thiow Kong ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Cell cycle; Cyclin E; Gastric cancer; P27; Prognosis; Survival

Indexed keywords

CYCLIN E; PROTEIN P27;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA;

EID: 0033758099     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5998     Document Type: Article

References (27)

1. Cancer cell cycles
2. Concurrent amplification of cyclin E and CDK 2 genes in colorectal carcinomas
3. A potential marker for breast cancer
4. Frequent amplification of the cyclin E gene in human gastric carcinomas
5. 1 cyclin-dependent kinases
6. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p 27 in aggressive colorectal carcinomas
7. Decreased levels of the cell-cycle inhibitor p27(KIP1) protein: Prognostic implications in primary breast cancer
8. Expression of cell-cycle regulators p27(KIP1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
9. Positive correlation between p27(KIP1) expression and progression of human esophageal squamous cell carcinoma
10. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
11. Loss of cyclin-dependent kinase inhibitor p 27KIP1 is a novel prognostic factor in localized human prostate adenocarcinoma
12. Reduced expression of cyclin-dependent kinase inhibitor p27(KIP1) is associated with advanced stage and invasiveness of gastric carcinomas
13. P 27 expression and gastric carcinoma
14. The Japanese Research society Committee on Histological Classification of Gastric Cancer
15. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues
16. Cell cyclecancer
17. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
18. Cloning of p27(KIP1), a new cyclin kinase inhibitor and a potential mediator of extracellular antimitogenic signals
19. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis and female sterility in p27(kip1) deficient mice
20. Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors
21. Mechanism for inactivation of the KIP family cyclln-dependent kinase inhibitor genes in gastric cancer cells
22. Down-regulation of p 27 is associated with development of colorectal adenocarcinoma metastases
23. Impact of the expression of cyclin-dependent kinase inhibitor p27 and apoptosis in tumor cells on the overall survival of patients with non-early gastric carcinoma
24. Cyclin D 2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases
25. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status
26. Association of down-regulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma
27. Prognostic value of cyclin E and p53 expression in gastric carcinoma